Porphyria cutanea tarda induced by olmesartan

J Eur Acad Dermatol Venereol. 2010 Aug;24(8):977-8. doi: 10.1111/j.1468-3083.2009.03549.x. Epub 2009 Dec 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Biopsy
  • Humans
  • Hypertension / drug therapy
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use
  • Male
  • Middle Aged
  • Porphyria Cutanea Tarda / chemically induced*
  • Porphyria Cutanea Tarda / diagnosis
  • Porphyria Cutanea Tarda / pathology
  • Skin / pathology
  • Tetrazoles / adverse effects*
  • Tetrazoles / therapeutic use

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Tetrazoles
  • olmesartan